Food and Drug Administration report describes concerning conditions at Baltimore site where manufacturing was halted
A US Food and Drug Administration inspection report found unsanitary conditions and other problems at a Baltimore manufacturing plant that ruined more than 15m doses of Johnson & Johnson coronavirus vaccine.
The FDA reported the plant operated by Emergent BioSolutions “is not maintained in a clean and sanitary condition”. The report says the paint on the plant’s walls were peeling in several areas and paint flecks were found on the floor.